HPV detection RUO assay

Ended Purchase Order Awarded

Contract number
75D30123P18192
Awardee
Awarding agency
Obligated
$85,500

Award facts

Opportunity
  • 75D30123Q77303 Solicitation number
Contract value 100% obligated
$85,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Irvine, CA 92618, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention. The award does not have a set-aside designation and is not associated with a larger contract vehicle. The contract has a completion date of September 30, 2023.

Quick answers

Who was awarded contract 75D30123P18192?

75D30123P18192 was awarded to Seegene Usa, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 21, 2023.

How much is contract 75D30123P18192 worth?

The government has obligated $85,500 on 75D30123P18192.

Was contract 75D30123P18192 competed?

The extent of competition for 75D30123P18192 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award